Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs
globalreutersNovember 3, 20241 Mins read 
Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington professor of biochemistry recently awarded the Nobel Prize in Chemistry for his work in computational protein design.
The post Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs appeared first on MedCity News.
Related Articles
Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum
Ensuring that family caregivers, and hospice providers all get the support that...
Coping with Winter Depression
Short and cloudy winter days can dwindle your energy, making you sluggish...
Understanding Heart Tumor Treatment in India: A Patient Guide
Dealing with a heart tumor can feel devastating. But, India might offer...
There is no placebo effect…but we still need them!
That is the argument from an interesting post on the Carcinisation website...
Leave a comment